
Fleury
Fleury works in prevention, diagnostic and therapeutic medicine.
Market cap
$1.2b
Enterprise value
$1.8b
Share price
BRL13.02 FLRY3.SA
Recent deals
- Healthcare
loading funding rounds…
BRL | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 30 % | 15 % | 45 % | 19 % | 7 % | 7 % | 6 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | 27 % | 28 % | 28 % | 28 % | 26 % | 26 % | 26 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | 9 % | 7 % | 7 % | 8 % | 8 % | 9 % | 9 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Equity research estimates
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Investments by Fleury
Edit
ACQUISITION by Fleury Apr 2021

ACQUISITION by Fleury May 2022

ACQUISITION by Fleury Oct 2022

ACQUISITION by Fleury Nov 2024